Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.
Federica PulvirentiFrancesco CinettoAntonio PecoraroMaria CarrabbaLudovica CrescenziRaffaella NeriLivia BonanniGiovanna FabioCarlo AgostiniGiuseppe SpadaroStefano TabolliAlbert FarrugiaIsabella QuintiCinzia MilitoPublished in: Journal of clinical immunology (2019)
IgRT schedules do not impact the HRQoL in CVID if the treatment is established after an extensive educational period focused on individualizing the best therapeutic regimen.
Keyphrases